LEADER 00000nam  2200000Ia 4500 
001    430835539    
003    OCoLC 
005    20090817144600.0 
006    m        d f       
007    cr an||||||||| 
008    090817s2000    mdu     s    f000 0 eng d 
040    GPO|cGPO|dGPO|dMvI 
074    0499-T (online) 
086 0  HE 20.4702:R 31b 
245 00 Guidance for industry|h[electronic resource] :|bsubmitting
       and reviewing complete responses to clinical holds. 
246 30 Submitting and reviewing complete responses to clinical 
       holds. 
260    Rockville, MD :|bU.S. Dept. of Health and Human Services, 
       Food and Drug Administration, Center for Drug Evaluation 
       and Research,|c[2000] 
300    1 online resource (5 p). 
500    "Center for Biologics Evaluation and Research". 
500    "User fees". 
500    "Revision 1". 
500    "October 2000". 
650  0 Drugs|xTesting|xGovernment policy|zUnited States. 
650  0 Clinical trials|xGovernment policy|zUnited States. 
710 2  Center for Drug Evaluation and Research (U.S.) 
710 2  Center for Biologics Evaluation and Research (U.S.) 
856 40 |uhttp://purl.access.gpo.gov/GPO/LPS115983 
LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE